SUN Li Li , GUAN Feng, WEI Wei, ZHANG Fan, CHEN Yi Hua, LIU Tian Ze
Objective The aim of this meta-analysis is to explore the effect of GnRHa down-regulation
pretreatment on the endometrial preparation and the pregnancy/live birth rate in RIF-FET women. Methods PubMed, EMBASE, Web of Science, Cochrane Library, CBM, CNKI, Weipu, and Wanfang databases were
searched to identify relevant randomized control trials (RCTs). Studies before Jun, 2022 were included for
primary screening. Meta-analysis of the endometrium thickness and clinical pregnancy rate were conducted. Results There was no statistical difference at baseline comparison of age [MD=0.10, 95%CI(-0.95,1.15),
(Z=0.19, P=0.85>0.1)]. The final selection enrolled 3 RCTs, involving 339 FET cycles. Compared with control
group, the pooled effective values indicated that GnRHa administration could improve endometrium thickness
[MD=0.42, 95%CI(-0.51, 1.34), Z=0.89, P=0.38>0.1] and clinical pregnancy rate [RR=1.47, 95%CI(0.96,
2.25), Z=1.78, P=0.07>0.05], but there was no statistical difference. Egger regression test (P=0.185>0.05) did
not demonstrate any significance for the publication bias. Conclusion GnRHa pretreatment had a beneficial
role on the outcomes of FET cycles for RIF patients. There was a trend towards improved endometrium thickness and
clinical pregnancy rate. However, the differences were not statistically significant. Therefore, additional large prospective
studies were necessary on this topic.